From: Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
Conditions
Dilution
Gentisic acid (mM)
Ascorbate (mM)
Ethanol % (v/v)
1
80 ×
1.0
4.0
–
2
70 ×
1.2
4.5
10
3
40 ×
2.0
7.9
4
15 ×
5.4
21.2
5*
9.0
35.4